In our series, PIK3CA mutations were most commonly seen in myxoid liposarcoma (23.5%), as well as in rhabdomyosarcoma (7.4%), solitary fibrous tumor (6.3%) and UPS (5.5%). The gene discussed is PIK3CA; the disease is myxoid liposarcoma.